Claassen MAA - Search Results

1

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.

Patmore LA, van Eekhout KMA, Buti M, Koc ÖM, Agarwal K, de Knegt RJ, Janssen HLA, van der Valk M, Lieveld FI, Hansen BE, Kramer M, de Bruijne J, Claassen MAA, Smit C, de Man RA, Takkenberg B, Carey I, Sonneveld MJ; HARP study group and HepNed. Patmore LA, et al. Among authors: claassen maa. J Hepatol. 2024 Feb;80(2):243-250. doi: 10.1016/j.jhep.2023.10.019. Epub 2023 Oct 26. J Hepatol. 2024. PMID: 37898348 Free article.

2

Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.

Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, van der Molen RG, Boonstra A. Stoop JN, et al. Clin Immunol. 2008 Dec;129(3):419-27. doi: 10.1016/j.clim.2008.07.029. Epub 2008 Sep 26. Clin Immunol. 2008. PMID: 18823821

3

Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.

Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A. Claassen MA, et al. J Hepatol. 2010 Mar;52(3):315-21. doi: 10.1016/j.jhep.2009.12.013. Epub 2009 Dec 24. J Hepatol. 2010. PMID: 20129690

4

Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Claassen MA, de Knegt RJ, Janssen HL, Boonstra A. Claassen MA, et al. J Virol. 2011 Jun;85(11):5323-30. doi: 10.1128/JVI.02551-10. Epub 2011 Mar 30. J Virol. 2011. PMID: 21450832 Free PMC article.

5

Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.

Claassen MA, de Knegt RJ, Turgut D, Groothuismink ZM, Janssen HL, Boonstra A. Claassen MA, et al. PLoS One. 2012;7(11):e49389. doi: 10.1371/journal.pone.0049389. Epub 2012 Nov 8. PLoS One. 2012. PMID: 23145169 Free PMC article.

6

Role of T cell immunity in hepatitis C virus infections.

Claassen MA, Janssen HL, Boonstra A. Claassen MA, et al. Curr Opin Virol. 2013 Aug;3(4):461-7. doi: 10.1016/j.coviro.2013.05.006. Epub 2013 Jun 2. Curr Opin Virol. 2013. PMID: 23735335 Review.

7

Controversy on the role of FoxP3⁺ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections.

Claassen MA, Janssen HL, de Knegt RJ, Boonstra A. Claassen MA, et al. J Hepatol. 2014 Jan;60(1):231-2. doi: 10.1016/j.jhep.2013.08.029. Epub 2013 Sep 14. J Hepatol. 2014. PMID: 24045149 Free article. No abstract available.

8

Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.

Hou J, van Oord G, Groothuismink ZM, Claassen MA, Kreefft K, Zaaraoui-Boutahar F, van IJcken WF, Osterhaus AD, Janssen HL, Andeweg AC, de Knegt RJ, Boonstra A. Hou J, et al. J Virol. 2014 Nov;88(21):12254-64. doi: 10.1128/JVI.00775-14. Epub 2014 Aug 6. J Virol. 2014. PMID: 25100847 Free PMC article.

9

The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.

Spaan M, Claassen MA, Hou J, Janssen HL, de Knegt RJ, Boonstra A. Spaan M, et al. J Infect Dis. 2015 Aug 1;212(3):386-90. doi: 10.1093/infdis/jiv059. Epub 2015 Jan 30. J Infect Dis. 2015. PMID: 25637348

10

Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients.

Hullegie SJ, Claassen MA, van den Berk GE, van der Meer JT, Posthouwer D, Lauw FN, Leyten EM, Koopmans PP, Richter C, van Eeden A, Bierman WF, Newsum AM, Arends JE, Rijnders BJ. Hullegie SJ, et al. J Hepatol. 2016 Apr;64(4):807-12. doi: 10.1016/j.jhep.2015.12.004. Epub 2015 Dec 12. J Hepatol. 2016. PMID: 26689767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page